ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | – | 1,056 | +162.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 403 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 403 | -58.2% | 0.00% | – |
| Q4 2021 | $3,000 | +200.0% | 964 | +221.3% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 300 | +56.2% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 192 | +8.5% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 177 | -42.7% | 0.00% | – |
| Q2 2020 | $1,000 | -50.0% | 309 | -21.6% | 0.00% | – |
| Q1 2020 | $2,000 | -60.0% | 394 | -43.8% | 0.00% | – |
| Q3 2019 | $5,000 | +150.0% | 701 | +645.7% | 0.00% | – |
| Q2 2019 | $2,000 | – | 94 | +154.1% | 0.00% | – |
| Q1 2019 | $0 | – | 37 | -77.8% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 167 | -16.1% | 0.00% | – |
| Q3 2017 | $2,000 | – | 199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ground Swell Capital, LLC | 25,445 | $19,000 | 0.05% |
| ETF MANAGERS GROUP, LLC | 2,258,970 | $1,654,000 | 0.05% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 116,780 | $85,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 131,036 | $96,000 | 0.01% |
| Bernardo Wealth Planning LLC | 30,469 | $20,000 | 0.01% |
| PCG Wealth Advisors, LLC | 15,200 | $12,000 | 0.00% |
| Penserra Capital Management LLC | 212,298 | $155,000 | 0.00% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $36,000 | 0.00% |
| King Wealth Management Group | 16,000 | $12,000 | 0.00% |
| Vident Investment Advisory, LLC | 105,398 | $77,000 | 0.00% |